FAR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.217500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.269800E-01
Normal-vs-Stage2
3.438400E-03
Normal-vs-Stage3
9.872300E-02
Normal-vs-Stage4
4.046800E-01
Stage1-vs-Stage2
8.087200E-01
Stage1-vs-Stage3
1.089000E-01
Stage1-vs-Stage4
9.397800E-01
Stage2-vs-Stage3
3.98810000001859E-06
Stage2-vs-Stage4
8.104800E-01
Stage3-vs-Stage4
1.716610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.259680E-02
Normal-vs-AfricanAmerican
3.375200E-01
Normal-vs-Asian
2.529800E-01
Caucasian-vs-AfricanAmerican
7.213200E-01
Caucasian-vs-Asian
5.588400E-01
AfricanAmerican-vs-Asian
5.003000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.265630E-02
Normal-vs-Female
4.261000E-01
Male-vs-Female
2.023800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.788000E-01
Normal-vs-Age(41-60Yrs)
4.513600E-01
Normal-vs-Age(61-80Yrs)
1.735860E-02
Normal-vs-Age(81-100Yrs)
1.378590E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.022800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.169200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.277230E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.271000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.374000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.297000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.127800E-01
Normal-vs-Daily Drinker
1.845970E-01
Normal-vs-Weekly Drinker
5.692800E-01
Normal-vs-Occasional Drinker
2.972400E-01
Normal-vs-Social Drinker
1.378800E-01
Non Drinker-vs-Daily Drinker
9.097800E-01
Non Drinker-vs-Weekly Drinker
9.027800E-01
Non Drinker-vs-Occasional Drinker
9.220600E-01
Non Drinker-vs-Social Drinker
5.965800E-01
Daily Drinker-vs-Weekly Drinker
8.560400E-01
Daily Drinker-vs-Occasional Drinker
8.692000E-01
Daily Drinker-vs-Social Drinker
7.376400E-01
Weekly Drinker-vs-Occasional Drinker
9.878800E-01
Weekly Drinker-vs-Social Drinker
6.091400E-01
Occasional Drinker-vs-Social Drinker
6.345800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.815800E-01
Normal-vs-Grade 2
1.750990E-01
Normal-vs-Grade 3
2.451200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.791400E-01
Grade 1-vs-Grade 3
9.105400E-01
Grade 1-vs-Grade 4
6.815800E-01
Grade 2-vs-Grade 3
5.766000E-01
Grade 2-vs-Grade 4
1.750990E-01
Grade 3-vs-Grade 4
2.451200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.686400E-01
Normal-vs-NonDiabetic
5.410400E-01
Diabetic-vs-NonDiabetic
8.496200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.298200E-01
Normal-vs-NoPancreatitis
5.358600E-01
Pancreatitis-vs-NoPancreatitis
9.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.585800E-01
Normal-vs-N1
6.784300E-03
N0-vs-N1
1.763600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.264510E-03
Normal-vs-TP53-NonMutant
4.509900E-02
TP53-Mutant-vs-TP53-NonMutant
9.953000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
